GlaxoSmithKline made headlines this week with the announcement that it expects offshoot its joint consumer healthcare venture Haleon. Haleon represents a joint venture between GSK
Made famous in the tech industry, moonshots are ambition ventures with the promise of near-term profitability. In the pharmaceutical industry, Vertex Pharmaceuticals, known for its
With names such as BetterHelp, a sub company of Teladoc Health, interrupting your favorite podcasts, the post-pandemic era represents a critical tipping point for the
Every life science product exists within an ecosystem comprised of key stakeholders. Understanding and addressing the needs of these stakeholders demands an integrated approach. To
AI in life sciences is here to stay. Artificial Intelligence (AI) and machine learning are rapidly accelerating the drug discovery and development process in the
Despite being discovered 65 years ago, messenger-RNA (mRNA), specifically mRNA vaccines, is making waves in the pharmaceutical industry. Pfizer/Biotech and Modernas’ COVID-19 vaccines credit their
With billions of dollars on the line, a thorough analysis of the market landscape for your life science product is of utmost importance. Entering new
The Pfizer COVID pill is the latest feat of strength from the New York-based pharmaceutical firm. To pair with its robust vaccine, Pfizer recently announced
“Stakeholder Analysis and Engagement are critical to the launch and staying power of your product.” You have heard that wisdom before, but on top of
In possibly the greatest product development race of this century, Pfizer, Moderna, and Johnson and Johnson (J&J) have emerged victorious. These firms beat out 6
